Metropolitan Life Insurance CO Aclaris Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $2,263 - $3,777	345 Added 9.7%	3,901 $26,000
Q2 2023 Aug 10, 2023	BUY	$7.89 - $10.64 $5,696 - $7,682	722 Added 25.48%	3,556 $36,000
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $10,887 - $27,643	-1,540 Reduced 35.21%	2,834 $22,000
Q4 2022 Jun 14, 2023	BUY	$14.33 - $18.37 $22,068 - $28,289	1,540 Added 54.34%	4,374 $68.9 Million
Q4 2022 Mar 30, 2023	BUY	$14.33 - $18.37 $10,675 - $13,685	745 Added 20.53%	4,374 $68,000
Q4 2022 Feb 15, 2023	BUY	$14.33 - $18.37 $10,675 - $13,685	745 Added 20.53%	4,374 $68,000
Q3 2022 Jun 14, 2023	BUY	$13.07 - $18.22 $10,390 - $14,484	795 Added 28.05%	3,629 $57.1 Million
Q2 2022 Jun 20, 2023	BUY	$10.16 - $17.08 $8,077 - $13,578	795 Added 28.05%	3,629 $50,000
Q2 2022 Mar 30, 2023	BUY	$10.16 - $17.08 $6,431 - $10,811	633 Added 21.13%	3,629 $50,000
Q2 2022 Aug 11, 2022	BUY	$10.16 - $17.08 $6,431 - $10,811	633 Added 21.13%	3,629 $51,000
Q1 2022 Jun 20, 2023	BUY	$9.74 - $17.92 $1,577 - $2,903	162 Added 5.72%	2,996 $51,000
Q1 2022 Mar 30, 2023	SELL	$9.74 - $17.92 $94,478 - $173,824	-9,700 Reduced 76.4%	2,996 $51,000
Q1 2022 May 12, 2022	SELL	$9.74 - $17.92 $94,478 - $173,824	-9,700 Reduced 76.4%	2,996 $52,000
Q4 2021 Jun 21, 2023	BUY	$12.27 - $18.49 $121,006 - $182,348	9,862 Added 347.99%	12,696 $184,000
Q3 2021 Jun 21, 2023	BUY	$13.38 - $18.8 $131,953 - $185,405	9,862 Added 347.99%	12,696 $228,000
Q2 2021 Jun 21, 2023	BUY	$17.08 - $29.6 $168,442 - $291,915	9,862 Added 347.99%	12,696 $222,000
Q2 2021 Mar 30, 2023	BUY	$17.08 - $29.6 $142,139 - $246,331	8,322 Added 190.26%	12,696 $222,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $216,847 - $375,801	12,696 New	12,696 $223,000
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $67,999 - $94,691	-12,078 Closed	0 $0
Q4 2018 Jul 13, 2023	BUY	$6.3 - $15.4 $58,237 - $142,357	9,244 Added 326.18%	12,078 $89,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $63,270 - $154,662	10,043 Added 493.51%	12,078 $89,000
Q3 2018 Jul 13, 2023	BUY	$14.38 - $20.89 $118,232 - $171,757	8,222 Added 290.12%	11,056 $161 Million
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $129,721 - $188,448	-9,021 Reduced 81.59%	2,035 $30,000
Q2 2018 Aug 15, 2018	BUY	$16.46 - $20.33 $59,074 - $72,964	3,589 Added 48.06%	11,056 $0
Q4 2017 Feb 15, 2018	SELL	$21.47 - $27.8 $148,293 - $192,014	-6,907 Reduced 48.05%	7,467 $184,000
Q2 2017 Aug 14, 2017	BUY	N/A	14,374	14,374 $390,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.2 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.8 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.8 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.4 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account